| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0005 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0007 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.61 | 0.0008 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0009 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.15 | 0.001 |